- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Clin Chim Acta. 2018 Jul 16. pii: S0009-8981(18)30374-7. doi: 10.1016/j.cca.2018.07.027. [Epub ahead of print]
Correlation between hepatitis B core-related antigen and HBV viral load in chronic hepatitis B and hepatocellular carcinoma patients.
Chen S1, Jia J2, Gao Y2, Li H2, Fang M2, Feng H2, Guan W1, Ji J2, Gao Z2, Gao C3.
Author information
1
Department of Laboratory Medicine, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, PR China; The First Clinical Medical College of Fujian Medical University, Fuzhou, PR China.
2
Department of Laboratory Medicine, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, PR China.
3
Department of Laboratory Medicine, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, PR China. Electronic address: [email protected].
Abstract
BACKGROUND:
Hepatitis B core-related antigen has been revealed as an important marker of HBV infection recently. We aimed to evaluate the HBcrAg assay for indication of HBV loads in chronic hepatitis B (CHB) and hepatocellular carcinoma patients (HCC).
METHODS:
HBcrAg was measured by chemiluminescence enzyme immunoassay. Intrahepatic covalently closed circular DNA (cccDNA) was measured by real-time PCR with TaqMan fluorescent probes based on liver biopsy specimens from HCC patients.
RESULTS:
HBcrAg correlated positively with HBV DNA irrespective of HBeAg status. Both HBcrAg and HBV DNA were associated with cccDNA in patients with elevated serum HBV DNA (>4 log IU/ml). In patients with non-elevated HBV DNA (≤4 log IU/ml), no relationship between HBV DNA and cccDNA was observed, but we still documented a modest correlation between HBcrAg and cccDNA. In addition, a decreased correlation between HBcrAg and cccDNA in HCC tumorigenesis was documented. Finally, a moderate correlation occurred between HBcrAg and albumin, alanine transaminase, aspartate transaminase in both CHB and HCC patients.
CONCLUSIONS:
Our data show that HBcrAg can serve as a biomarker to assess HBV loads in patients and provide a better method for monitoring cccDNA in HCC patients than HBV DNA.
Copyright © 2018. Published by Elsevier B.V.
KEYWORDS:
Chronic hepatitis B (CHB); Covalently closed circular DNA (cccDNA); HBV DNA; HBcrAg; Hepatocellular carcinoma (HCC)
PMID:
30025756
DOI:
10.1016/j.cca.2018.07.027 |
|